Tissue Regenix Group Delists from London Bourse's AIM Segment

02:55 AM EST, 01/07/2026 (MT Newswires) -- Tissue Regenix Group (TRX.L) shares were delisted from the London stock exchange's AIM segment at 7 am local time on Wednesday, according to a same-day release. The regenerative medical devices company shares will be traded via an electronic off-market dealing facility operated by the UK Financial Conduct Authority-authorized firm Asset Match after the cancellation.